Skip to main content
. 2004 Dec;48(12):4680–4686. doi: 10.1128/AAC.48.12.4680-4686.2004

FIG. 2.

FIG. 2.

Antiviral activity of TMC125 and current NNRTIs tested against a panel of 25 HIV-1 strains harboring one or two NNRTI resistance-associated mutations. HIV-1 strains were constructed by site-directed mutagenesis as described in Materials and Methods. NVP, nevirapine; DLV, delavirdine, EFV, efavirenz.